<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Medical and Human Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8DF8C226-C119-42E0-A540-7ED4C69173B6"><gtr:id>8DF8C226-C119-42E0-A540-7ED4C69173B6</gtr:id><gtr:name>Varian Ltd</gtr:name><gtr:address><gtr:line1>Varian Limited</gtr:line1><gtr:line2>6 Mead Road</gtr:line2><gtr:line3>Oxford Industrial Park</gtr:line3><gtr:line4>Kidlington</gtr:line4><gtr:line5>Oxfordshire</gtr:line5><gtr:postCode>OX5 1QU</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/84EC36D9-AAC8-496A-B69B-F9DE2213B154"><gtr:id>84EC36D9-AAC8-496A-B69B-F9DE2213B154</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/3CF9EB25-5323-4160-9802-0B125921F055"><gtr:id>3CF9EB25-5323-4160-9802-0B125921F055</gtr:id><gtr:firstName>Stuart</gtr:firstName><gtr:otherNames>McRae</gtr:otherNames><gtr:surname>Allan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/35F21D05-1C0B-444B-AB16-AB53FD23A5C9"><gtr:id>35F21D05-1C0B-444B-AB16-AB53FD23A5C9</gtr:id><gtr:firstName>Mark R.</gtr:firstName><gtr:surname>Boyett</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/858A3E30-2467-4F98-B894-DE66B12AECF0"><gtr:id>858A3E30-2467-4F98-B894-DE66B12AECF0</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:otherNames>M.</gtr:otherNames><gtr:surname>Luckman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8F4814A9-89E1-47D5-833A-B05FE493A7C5"><gtr:id>8F4814A9-89E1-47D5-833A-B05FE493A7C5</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Stratford</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F0A3F403-8578-47AC-A520-9E6B1EDFC18F"><gtr:id>F0A3F403-8578-47AC-A520-9E6B1EDFC18F</gtr:id><gtr:firstName>Bill</gtr:firstName><gtr:surname>Deakin</gtr:surname><gtr:orcidId>0000-0002-2750-962X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9370EB52-19BF-4601-A002-75DAA1BA1220"><gtr:id>9370EB52-19BF-4601-A002-75DAA1BA1220</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Buckley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DD273593-1D6E-492D-8E50-FFC6D2D2E976"><gtr:id>DD273593-1D6E-492D-8E50-FFC6D2D2E976</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>Ross</gtr:otherNames><gtr:surname>Williams</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FF011350%2F1"><gtr:id>51B71C67-1B47-4C6E-A1B8-AB3CC0AAE2D7</gtr:id><gtr:title>A New Magnetic Resonance Imaging Console for the 7 Tesla Small Bore Animal Imaging Facility</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/F011350/1</gtr:grantReference><gtr:abstractText>This proposal to BBSRC is for new equipment to enable images to be taken of intact biological specimens ranging from isolated organs (including human heart tissue) through to living animals. The technology we will use is magnetic resonance imaging (MRI), which is a non-destructive method to take images of superb clarity and detail from within living subjects without using harmful radiation. MRI is widely used for imaging patients in hospitals, and we are proposing to purchase similar equipment for imaging much smaller subjects, such as rats and mice. One of the advantages of MRI is that it is a very versatile technique which can be used in a number of different ways / in this proposal we include three different studies of the brain: one in which we look for regions of the brain which are important in regulating appetite; another in which we are interested in where drugs which alter states of mind act; and a third in which we wish to understand how inflammation (the process by which the body responds to an infection or allergy) affects the brain. We are not restricting our study to the brain / we will also use imaging to find out about detailed structure of the heart, to discover mechanisms which lead to the formation of new blood vessels, and finally by imaging, after death, the heads of a number of specimens of different mammalian species (including some valuable samples stored in museums) we hope to improve our understanding of how mammals move and maintain their balance. The versatility of the technique means that it can be used to help provide answers to a large range of scientific questions in biology, and by this purchase we will be able to provide the opportunity to local researchers to undertake state-of-the-art imaging studies for several years to come.</gtr:abstractText><gtr:technicalSummary>This proposal is to support the purchase of a new MRI console to be interfaced to an existing horizontal bore 7 T animal imaging magnet. It will be used to continue funded research in a number of collaborations in neuroscience and cardiovascular research. We will use pharmacological challenge functional MRI (pMRI) in two projects / one in which we will probe appetite control in the brain and the other in which we will investigate how inhibition of the NMDA receptor exerts downstream effects on other neurotransmitter systems. In appetite regulation, it is an open question as to how homeostatic and hedonistic mechanisms interact to control eating behaviour, and we will use pMRI together with specific pharmacological challenges to identify the brain areas and neurotransmitter systems which are involved in these two processes. We will then use these data to interpret how ghrelin / the putative 'hunger' signal acts. We will use sub-anaesthetic doses of ketamine to inhibit NMDA activity in vivo, and by combining this with pre-treatment with other agents and comparing to a more potent inhibitor, phencyclidine, we will test the hypothesis that NMDA inhibition exerts downstream effects through paradoxically stimulating glutamate release. A third neuroscience project in vivo will use pMRI to characterize the effects of inflammatory mediators, in particular to determine their interaction with glutamate neurotransmission. Structural imaging of fixed specimens will be used in a comparative biology project to understand the vestibular-ocular reflex and how it develops in different ways in different mammals. In cardiovascular science we will use structural and diffusion weighted imaging of fixed hearts to provide data to generate 3-D biophysical models of the heart, and in the final project dynamic contrast enhanced imaging will be used to characterize molecular and genetic signals which control angiogenesis.</gtr:technicalSummary><gtr:fund><gtr:end>2009-05-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-05-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>220329</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B1E14974-5909-411B-B47E-6A76818E198F</gtr:id><gtr:title>A biomimetic tumor tissue phantom for validating diffusion-weighted MRI measurements.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2921d8e67ad18442d0fe3f88e2d912e"><gtr:id>f2921d8e67ad18442d0fe3f88e2d912e</gtr:id><gtr:otherNames>McHugh DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>5a2fce8d1ccbc0.20426728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11F0F492-2D56-4397-B800-66C9E6B06619</gtr:id><gtr:title>Differential Effects of Anaesthesia on the phMRI Response to Acute Ketamine Challenge.</gtr:title><gtr:parentPublicationTitle>British journal of medicine and medical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/919101ed7e8e2c975dc827bcc4fb458d"><gtr:id>919101ed7e8e2c975dc827bcc4fb458d</gtr:id><gtr:otherNames>Hodkinson DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2231-0614</gtr:issn><gtr:outcomeId>pm_15354_24_22737655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B877BCC8-1A0E-454C-AAA1-9D73182114D4</gtr:id><gtr:title>Tailoring the surface charge of dextran-based polymer coated SPIONs for modulated stem cell uptake and MRI contrast.</gtr:title><gtr:parentPublicationTitle>Biomaterials science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5035edf2ebc5c5786b97b8b72ddbda71"><gtr:id>5035edf2ebc5c5786b97b8b72ddbda71</gtr:id><gtr:otherNames>Barrow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2047-4830</gtr:issn><gtr:outcomeId>doi_55f94b94b37c70e9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28DB6243-4BD6-4749-9FAE-A26C45B60059</gtr:id><gtr:title>Poly[2-(methacryloyloxy)ethylphosphorylcholine]-coated iron oxide nanoparticles: synthesis, colloidal stability and evaluation for stem cell labelling.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/360693d62e5a4f5f7c18f6d4af5610a5"><gtr:id>360693d62e5a4f5f7c18f6d4af5610a5</gtr:id><gtr:otherNames>Peacock AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>54622e951de0e0.15736437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88E520BC-B8B2-4A86-893C-2ADB6C83F5A5</gtr:id><gtr:title>Biomimetic phantom for the validation of diffusion magnetic resonance imaging.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/965666427eb66edd85871c3a68198295"><gtr:id>965666427eb66edd85871c3a68198295</gtr:id><gtr:otherNames>Hubbard PL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>5462325e80ee53.45814845</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56ABDF6F-BD1D-4BBB-AFBF-EB98986F9611</gtr:id><gtr:title>MS-1 magA: Revisiting Its Efficacy as a Reporter Gene for MRI.</gtr:title><gtr:parentPublicationTitle>Molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be943c808354c333261647a7e3ae2a9b"><gtr:id>be943c808354c333261647a7e3ae2a9b</gtr:id><gtr:otherNames>Pereira SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1535-3508</gtr:issn><gtr:outcomeId>585d700f22d389.88370039</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>023C1936-7954-438B-9B7C-09D402EA7D61</gtr:id><gtr:title>Evaluating the effectiveness of transferrin receptor-1 (TfR1) as a magnetic resonance reporter gene.</gtr:title><gtr:parentPublicationTitle>Contrast media &amp; molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be943c808354c333261647a7e3ae2a9b"><gtr:id>be943c808354c333261647a7e3ae2a9b</gtr:id><gtr:otherNames>Pereira SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1555-4309</gtr:issn><gtr:outcomeId>585d3dc9248532.96777548</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1352ACF6-EA9F-47EF-9969-AEAA0B29EE3E</gtr:id><gtr:title>Differential Effects of Anaesthesia on the phMRI Response to Acute Ketamine Challenge.</gtr:title><gtr:parentPublicationTitle>British journal of medicine and medical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/222849fbc29bcb43996d16214cf2b432"><gtr:id>222849fbc29bcb43996d16214cf2b432</gtr:id><gtr:otherNames>Stephen Williams (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>2231-0614</gtr:isbn><gtr:outcomeId>m_70614305421398aeb4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7031A38-DEAC-4E62-8435-36A07BE19A10</gtr:id><gtr:title>Longitudinal investigation of neuroinflammation and metabolite profiles in the APP&amp;times;PS1transgenic mouse model of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be067f24f51cb516b4af6ea11f9ef788"><gtr:id>be067f24f51cb516b4af6ea11f9ef788</gtr:id><gtr:otherNames>Chaney A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>5a93eac3ae76e9.00957651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABADAFD5-E9FB-4971-9A5F-91D0A6DDCFC7</gtr:id><gtr:title>Magnetic resonance spectroscopy in vivo of neurochemicals in a transgenic model of Alzheimer's disease: a longitudinal study of metabolites, relaxation time, and behavioral analysis in TASTPM and wild-type mice.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3afeb4df6bb1b4ed5998d084ce0e847a"><gtr:id>3afeb4df6bb1b4ed5998d084ce0e847a</gtr:id><gtr:otherNames>Forster D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>pm_15354_24_22760762</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B92ABBA-C44A-4B26-9DF9-3CC8A806FA74</gtr:id><gtr:title>Effects of Alzheimer's disease transgenes on neurochemical expression in the mouse brain determined by &amp;sup1;H MRS in vitro.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2bd7adf8b1b6567992d56d26455acdd"><gtr:id>d2bd7adf8b1b6567992d56d26455acdd</gtr:id><gtr:otherNames>Forster DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>pm_15354_24_22241671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5384BF18-D678-4AC9-B6BA-B0CE94BE1700</gtr:id><gtr:title>Data-driven mapping of hypoxia-related tumor heterogeneity using DCE-MRI and OE-MRI.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09e656fa51860ac938bbd2ecf1869ae1"><gtr:id>09e656fa51860ac938bbd2ecf1869ae1</gtr:id><gtr:otherNames>Featherstone AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>5a93ec57809c97.69370868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EEF5899-864D-47AF-84A7-CBD2B47609A9</gtr:id><gtr:title>P.2.025 A novel KV3 ion channel modulator restores cognitive function in an animal model of cognitive impairment in schizophrenia</gtr:title><gtr:parentPublicationTitle>European Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c77f7cfe65882656dc66f7cb906fff1"><gtr:id>3c77f7cfe65882656dc66f7cb906fff1</gtr:id><gtr:otherNames>Leger M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54623a190c4a23.10206854</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2F333C3-83F7-4559-B05D-AE190BE7D403</gtr:id><gtr:title>Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e0ff2e74a9a2da5c9a1d1f751fc39d0"><gtr:id>9e0ff2e74a9a2da5c9a1d1f751fc39d0</gtr:id><gtr:otherNames>Pradillo JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>546231c7b3b236.70129900</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC210F2B-8F84-47F9-A1F6-04B2FB6ECC80</gtr:id><gtr:title>Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemia.</gtr:title><gtr:parentPublicationTitle>Brain, behavior, and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e0ff2e74a9a2da5c9a1d1f751fc39d0"><gtr:id>9e0ff2e74a9a2da5c9a1d1f751fc39d0</gtr:id><gtr:otherNames>Pradillo JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0889-1591</gtr:issn><gtr:outcomeId>5a93ec575a52a8.02977904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7602092-6EDB-4CB5-A35B-100A2CE40691</gtr:id><gtr:title>Fe3O4-PEI-RITC magnetic nanoparticles with imaging and gene transfer capability: development of a tool for neural cell transplantation therapies.</gtr:title><gtr:parentPublicationTitle>Pharmaceutical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ca8c3fbce1152a76269b64e55145c4c"><gtr:id>3ca8c3fbce1152a76269b64e55145c4c</gtr:id><gtr:otherNames>Yiu HH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0724-8741</gtr:issn><gtr:outcomeId>54622e95437811.25838067</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3024AFE8-567D-4A73-8D74-C3D5F0BD17BF</gtr:id><gtr:title>Apparent diffusion coefficient is highly reproducible on preclinical imaging systems: Evidence from a seven-center multivendor study.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance imaging : JMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5432850cfc561ed0e3ab0c0b30e9880"><gtr:id>f5432850cfc561ed0e3ab0c0b30e9880</gtr:id><gtr:otherNames>Doblas S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1053-1807</gtr:issn><gtr:outcomeId>5a93ec57d7dd62.83363986</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>122B975C-A484-4FED-9D7D-5C4CD8E9AB28</gtr:id><gtr:title>Oxygen Enhanced Optoacoustic Tomography (OE-OT) Reveals Vascular Dynamics in Murine Models of Prostate Cancer.</gtr:title><gtr:parentPublicationTitle>Theranostics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7541bb13c71cb46af3710cd792c33592"><gtr:id>7541bb13c71cb46af3710cd792c33592</gtr:id><gtr:otherNames>Tomaszewski MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1838-7640</gtr:issn><gtr:outcomeId>5a93ec5726c839.03042557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AD50AA8-AAC0-4B20-90DC-A1C4E8084033</gtr:id><gtr:title>Overexpression of the MRI Reporter Genes Ferritin and Transferrin Receptor Affect Iron Homeostasis and Produce Limited Contrast in Mesenchymal Stem Cells.</gtr:title><gtr:parentPublicationTitle>International journal of molecular sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be943c808354c333261647a7e3ae2a9b"><gtr:id>be943c808354c333261647a7e3ae2a9b</gtr:id><gtr:otherNames>Pereira SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1422-0067</gtr:issn><gtr:outcomeId>5675e8abd059c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>477870CA-A7CE-46D6-A36F-7C3D3C036CF7</gtr:id><gtr:title>A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69e4075dcf805cade4de90af656b48d3"><gtr:id>69e4075dcf805cade4de90af656b48d3</gtr:id><gtr:otherNames>Maysami S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>5a93ec57a60c98.27229362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AD4DA58-2896-4C38-A269-C31B6D19A71D</gtr:id><gtr:title>Multifunctional Fe3O4 nanoparticles for targeted bi-modal imaging of pancreatic cancer</gtr:title><gtr:parentPublicationTitle>Journal of Materials Chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbe685194da364239596b4be19203dcd"><gtr:id>dbe685194da364239596b4be19203dcd</gtr:id><gtr:otherNames>Olariu C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>54623059b0bb01.56455021</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02865F68-4A8B-454F-B30C-486737E64D1D</gtr:id><gtr:title>Functional magnetic resonance imaging and c-Fos mapping in rats following a glucoprivic dose of 2-deoxy-D-glucose.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e6e61fdf3fe858d862b81b823c2108d"><gtr:id>7e6e61fdf3fe858d862b81b823c2108d</gtr:id><gtr:otherNames>Dodd GT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>54622f08858629.21574244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62C94F9B-68C4-4EBC-ACAD-2B0271A2FF8E</gtr:id><gtr:title>Central functional response to the novel peptide cannabinoid, hemopressin.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e6e61fdf3fe858d862b81b823c2108d"><gtr:id>7e6e61fdf3fe858d862b81b823c2108d</gtr:id><gtr:otherNames>Dodd GT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>54622f7820b785.11985623</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0426AE2-491B-4437-867D-41657DE0C0ED</gtr:id><gtr:title>Systemic inflammation impairs tissue reperfusion through endothelin-dependent mechanisms in cerebral ischemia.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3bf21b6bd5f7659d76de5a796e4311d"><gtr:id>b3bf21b6bd5f7659d76de5a796e4311d</gtr:id><gtr:otherNames>Murray KN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>56cb24ba9f5bd4.74916763</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/F011350/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>